A middle lobe sparing sleeve resection versus bilobectomy for right lower central non-small cell lung cancer: a retrospective propensity score matched cohort study.

val and disease-free survival were found between RLS and RLB groups in our study.A 100% R0 rate was achieved in all right lower sleeve resections, which confirming the oncological efficacy of this middle lobe sparing procedure.What is worth mentioning, the overall survival in sleeve resection group showed a trend towards superiority than the bilobectomy group after 36 months, which might be interpreted by that patients receiving bilobectomy were associated with a higher non-cancer death risk owning to a limited cardiopulmonary reservation.

also in 53,322 other papers